Abridge

Abridge is a healthcare AI company based in Pittsburgh, United States, founded in 2018. AI clinical documentation for doctors. It was valued at $5.3bn on 24 June 2025 (Series E funding round ($300m)), which makes it a unicorn in the 311 Unicorn Index.

Part of the 311 Unicorn Index (311institute.com). Last updated 16 October 2026.

About Abridge

AI clinical documentation for doctors. Lead investors in its latest round: Andreessen Horowitz. Website: abridge.com.

How this figure is calculated

The valuation set by the latest priced funding round or company-run share sale, as announced by the company or its lead investor, or reported by a major news organisation. Figures in other currencies are converted at the rate on the day of the round. Talks that have been reported but not closed do not count.

Related

• Innovation profile of Pittsburgh
• United States: economy and key statistics
• The 311 Unicorn Index
• Global Startups Directory
• Global Investors Directory
• All 311 Indexes

Other unicorns in United States

• Anthropic ($965bn)
• OpenAI ($852bn)
• Databricks ($190bn)
• Stripe ($159bn)
• Anduril Industries ($61bn)
• Ramp ($60bn)
• Cognition ($48bn)
• Project Prometheus ($41bn)
• Ripple ($40bn)
• Figure AI ($39bn)
• Safe Superintelligence ($32bn)
• Crusoe Energy Systems ($30.9bn)
• VAST Data ($30bn)
• Scale AI ($29bn)
• The Boring Company ($23bn)

Questions and answers

© 311 Institute 2026. Facts from the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.